• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMerck

Merck

Page 3 of 9
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
Health
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By Frank Connelly and BloombergNovember 4, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By David MeyerOctober 27, 2021
Merck & Co. headquarters in Kenilworth, N.J.
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
By James Paton and BloombergOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By Thomas Mulier, Riley Griffin and BloombergOctober 8, 2021
Merck's antiviral pill for COVID-19
Health
Everything to know about Merck’s COVID antiviral pill
By Emily MullinOctober 5, 2021
Shares of vaccine makers slump as Merck unveils data from its ‘game-changer’ COVID pill
Health
Shares of vaccine makers slump as Merck unveils data from its ‘game-changer’ COVID pill
By Abhishek Vishnoi and BloombergOctober 4, 2021
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By Matthew Perrone and The Associated PressOctober 1, 2021
Ivermectin
Health
The psychology behind why people will take horse paste, but not COVID vaccines
By Sy MukherjeeSeptember 2, 2021
Ivermectin Drug For COVID
Health
Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world
By Sophie MellorSeptember 2, 2021
Moderna vaccine
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By Sy MukherjeeAugust 5, 2021
IBM, Merck and OneTen launch network to recruit and promote Black workers over the next decade
Tech
IBM, Merck and OneTen launch network to recruit and promote Black workers over the next decade
By Jeff Green and BloombergJune 29, 2021
Merck takes huge hit for its abandoned COVID-19 drug efforts
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By Riley Griffin and BloombergMay 6, 2021
Best-Workplaces-Healthcare-2021-Methodist-Le-Bonheur-featured
Leadership
How Abbott, Merck, and more health care and biopharma companies took care during COVID
By Claire Hastwell and Great Place To WorkMarch 12, 2021
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
Health
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
By Andrew MarquardtMarch 2, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
...9
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.